Autolus Therapeutics Ltd reported -3522000 in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AstraZeneca USD 11.98B 637M Jun/2025
Autolus Therapeutics Ltd -3522000 5.45M Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Novartis USD 11.51B 1.12B Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Silence Therapeutics -1632000 408K Sep/2024